nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—HRH2—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.148	0.154	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0402	0.042	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0394	0.0412	CbGpPWpGaD
Nizatidine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0389	0.0406	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0338	0.0353	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0331	0.0346	CbGpPWpGaD
Nizatidine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.033	0.0345	CbGpPWpGaD
Nizatidine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0328	0.0343	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0239	0.0249	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.023	0.024	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0222	0.0232	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0215	0.0225	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0211	0.0221	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0209	0.0218	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0201	0.021	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0194	0.0203	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0187	0.0195	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0181	0.0189	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0178	0.0186	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0175	0.0183	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0163	0.0171	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0137	0.0143	CbGpPWpGaD
Nizatidine—HRH2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0136	0.0142	CbGpPWpGaD
Nizatidine—HRH2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0114	0.012	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00811	0.00848	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00776	0.00811	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0077	0.00804	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0076	0.00795	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00755	0.00789	CbGpPWpGaD
Nizatidine—HRH2—cardiovascular system—attention deficit hyperactivity disorder	0.007	0.162	CbGeAlD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00665	0.00695	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00651	0.00681	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00622	0.0065	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00527	0.00551	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00506	0.00529	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00496	0.00518	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00461	0.00481	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00452	0.00472	CbGpPWpGaD
Nizatidine—HRH2—nervous system—attention deficit hyperactivity disorder	0.00449	0.104	CbGeAlD
Nizatidine—HRH2—central nervous system—attention deficit hyperactivity disorder	0.00433	0.1	CbGeAlD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00428	0.00448	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00427	0.00446	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00415	0.00434	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00415	0.00433	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00408	0.00426	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00403	0.00421	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00395	0.00412	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00387	0.00405	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00375	0.00392	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00367	0.00383	CbGpPWpGaD
Nizatidine—BCHE—forebrain—attention deficit hyperactivity disorder	0.00361	0.0835	CbGeAlD
Nizatidine—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00357	0.00373	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00355	0.00371	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00349	0.00365	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00345	0.00361	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00344	0.00359	CbGpPWpGaD
Nizatidine—HRH2—brain—attention deficit hyperactivity disorder	0.00344	0.0795	CbGeAlD
Nizatidine—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00332	0.00347	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00321	0.00336	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00318	0.00333	CbGpPWpGaD
Nizatidine—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00305	0.0706	CbGeAlD
Nizatidine—HRH2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00301	0.00314	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00296	0.00309	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00286	0.00299	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0028	0.00293	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00279	0.00292	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00274	0.00286	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00271	0.00283	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00266	0.00278	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00263	0.00275	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00263	0.00275	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0026	0.00272	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00255	0.00266	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00254	0.00266	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00252	0.00263	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0025	0.00261	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00245	0.00256	CbGpPWpGaD
Nizatidine—BCHE—midbrain—attention deficit hyperactivity disorder	0.00238	0.0551	CbGeAlD
Nizatidine—HRH2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00229	0.00239	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00227	0.00237	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00225	0.00235	CbGpPWpGaD
Nizatidine—BCHE—nervous system—attention deficit hyperactivity disorder	0.00196	0.0453	CbGeAlD
Nizatidine—HRH2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00194	0.00203	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00193	0.00201	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00191	0.002	CbGpPWpGaD
Nizatidine—BCHE—central nervous system—attention deficit hyperactivity disorder	0.00189	0.0436	CbGeAlD
Nizatidine—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00184	0.0427	CbGeAlD
Nizatidine—HRH2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00179	0.00187	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00176	0.00184	CbGpPWpGaD
Nizatidine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00172	0.0398	CbGeAlD
Nizatidine—HRH2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00171	0.00179	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00171	0.00179	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0017	0.00178	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00163	0.0017	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00158	0.00165	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00154	0.00161	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00153	0.0016	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00153	0.0016	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0015	0.00157	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0015	0.00157	CbGpPWpGaD
Nizatidine—BCHE—brain—attention deficit hyperactivity disorder	0.0015	0.0347	CbGeAlD
Nizatidine—HRH2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00148	0.00155	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00147	0.00154	CbGpPWpGaD
Nizatidine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00145	0.0337	CbGeAlD
Nizatidine—HRH2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00143	0.0015	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00139	0.00145	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00138	0.00145	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00136	0.00143	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00135	0.00141	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00128	0.00134	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00126	0.00131	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00122	0.00128	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00116	0.00121	CbGpPWpGaD
Nizatidine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00114	0.0263	CbGeAlD
Nizatidine—HRH2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00104	0.00109	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000969	0.00101	CbGpPWpGaD
Nizatidine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000934	0.0216	CbGeAlD
Nizatidine—HRH2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000911	0.000952	CbGpPWpGaD
Nizatidine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000899	0.0208	CbGeAlD
Nizatidine—HRH2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00088	0.000919	CbGpPWpGaD
Nizatidine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000879	0.0203	CbGeAlD
Nizatidine—HRH2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000847	0.000885	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00082	0.000857	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000806	0.000843	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000801	0.000837	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000801	0.000837	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000796	0.000832	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000788	0.000824	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000742	0.000775	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000733	0.000766	CbGpPWpGaD
Nizatidine—ABCB1—brain—attention deficit hyperactivity disorder	0.000714	0.0165	CbGeAlD
Nizatidine—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000641	0.00067	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00061	0.000637	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000595	0.000622	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000566	0.000592	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000546	0.000571	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00052	0.000543	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000485	0.000507	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000482	0.000504	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000467	0.000489	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000391	0.000409	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000391	0.000409	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000385	0.000402	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000358	0.000374	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000313	0.000327	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000298	0.000311	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000275	0.000288	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000237	0.000248	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000235	0.000246	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	0.000208	0.000218	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000102	0.000106	CbGpPWpGaD
